13 Analysts Have This to Say About GoodRx Holdings
Portfolio Pulse from Benzinga Insights
Over the last quarter, 13 analysts have provided ratings for GoodRx Holdings (NASDAQ:GDRX), with 3 being bullish, 1 somewhat bullish, and 9 indifferent. The average 12-month price target for the company is $8.58, a 34.06% increase from the previous average of $6.40.

August 10, 2023 | 9:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
GoodRx Holdings has received mixed ratings from analysts, with the majority being indifferent. The average 12-month price target has increased significantly.
The mixed analyst ratings indicate uncertainty about the company's performance. However, the significant increase in the average 12-month price target suggests that analysts see potential for growth in the company's stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100